U-Blot® Research Grade Anti-Human CD223/LAG3 (IMP761)Cat. No. WA1444Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD223/LAG3 (IMP761)Cat. No. WA1444
U-Blot® Research Grade Anti-Human CD223/LAG3 (IMP-701)Cat. No. WA1443
U-Blot® Research Grade Anti-Human CD223/LAG3 (GSK2831781)Cat. No. WA1442
U-Blot® Research Grade Anti-Human CD223/LAG3 (ENUM006)Cat. No. WA1441
U-Blot® Research Grade Anti-Human CD223/LAG3 (DNV3)Cat. No. WA1440
U-Blot® Research Grade Anti-Human CD223/LAG3 (AVA-017)Cat. No. WA1439
U-Blot® Research Grade Anti-Human CD223/LAG3 (AM0003)Cat. No. WA1438
U-Blot® Research Grade Anti-Human CD221/IGF1R Antibody (AVE1642)Cat. No. WA1437
U-Blot® Research Grade Anti-Human CD221/IGF1R (VRDN-002)Cat. No. WA1436
U-Blot® Research Grade Anti-Human CD221/IGF1R (VPI-2690B)Cat. No. WA1435
U-Blot® Research Grade Anti-Human CD221/IGF1R (FPI-1434)Cat. No. WA1434
U-Blot® Research Grade Anti-Human CD221/IGF1R (BIIB022)Cat. No. WA1433